Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > CYTY

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Mar 14, 2023 12:57pm

46 Views

Post# 35337696

RE:CYTY

Oh I forgot they are over the counter so no letter for being under 1$ and still. No analyst with 9$ targets either. They don't have a 2M hight profile CEO either. Just to put in perspective that such oddities exist in the world we live in.

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects